Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (9), 1400-1406
- https://doi.org/10.1016/s0959-8049(97)00122-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancerAnnals of Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Chemotherapy for ovarian cancerEuropean Journal Of Cancer, 1993
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.Journal of Clinical Oncology, 1992
- Medical audit, cancer registration, and survival in ovarian cancerThe Lancet, 1991
- Cisplatin Combined With Carboplatin: A New Way of Intensification of Platinum Dose in the Treatment of Advanced Ovarian CancerJNCI Journal of the National Cancer Institute, 1990
- Phase I study of oxaliplatin in patients with advanced cancerCancer Chemotherapy and Pharmacology, 1990
- Reporting results of cancer treatmentCancer, 1981
- 1,2-Diaminocyclohexane Platinum Derivatives of Potential Clinical ValuePublished by Springer Nature ,1980